Gert-Jan Kootstra - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Nederlands Tijdschrift Voor Geneeskunde|August 5, 2020

[A man with painful shins]Frank W Snel, Gert-Jan Kootstra, Harald E Vonkeman

The Lancet. Gastroenterology & Hepatology|January 21, 2019

Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trialAnne Boerekamps, Anja De Weggheleire, Guido E van den Berk, et al.

Open Forum Infectious Diseases|April 3, 2024

Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort StudyMarta Vasylyev, Ferdinand W N M Wit, Carlijn C E Jordans, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Nederlands Tijdschrift Voor Geneeskunde|August 5, 2020

[A man with painful shins]Frank W Snel, Gert-Jan Kootstra, Harald E Vonkeman

The Lancet. Gastroenterology & Hepatology|January 21, 2019

Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trialAnne Boerekamps, Anja De Weggheleire, Guido E van den Berk, et al.

Open Forum Infectious Diseases|April 3, 2024

Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort StudyMarta Vasylyev, Ferdinand W N M Wit, Carlijn C E Jordans, et al.

Pageof 1